Neurogene Inc.

NGNE · Healthcare · Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases

Neurogene Inc. (NGNE), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 3 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jul 7 and filed Jul 8. The most active filer was Christine Mikail Cvijic with 4 filings.

Add to watchlist

Filings, ttm

0 buys · 3 sells

Traders, ttm

1 insider

Volume, ttmiDollar value disclosed in the window

$572K

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 7

Filed Jul 7

ADViAverage daily dollar volume

$7.6M

market data

Share price · 12M

$36.19 (+113.1%)

Adjusted for splits and dividends.

Volume by month

Buys $2.7M Sells $675K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Christine Mikail Cvijic President and CFO 4 filings SA

Srinivas Akkaraju Director 1 filing SC

Stuart Cobb Chief Scientific Officer 1 filing RM

Rachel McMinn Chief Executive Officer 1 filing

Recent filings

Christine Mikail CvijicSALE President and CFO $152K
4,200 sh × $36.13
Exec Jul 7
Filed Jul 7 · 9:08 PM ET Christine Mikail CvijicSALE President and CFO $300K
9,600 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET Christine Mikail CvijicSALE President and CFO $121K
4,800 sh × $25.11
Exec Feb 27
Filed Mar 3 · 5:30 PM ET Stuart CobbSALE Chief Scientific Officer $103K
6,797 sh × $15.15
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET Srinivas AkkarajuPURCHASE 10% owner $1.2M
46,770 sh across 3 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET Rachel McMinnPURCHASE Chief Executive Officer $969K
47,500 sh × $20.40
Exec Nov 22 2024
Filed Nov 25 2024 · 5:30 PM ET Christine Mikail CvijicPURCHASE President and CFO $492K
24,000 sh × $20.48
Exec Nov 22 2024
Filed Nov 25 2024 · 5:30 PM ET